{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:35:18Z","timestamp":1789504518593,"version":"build-2803163510"},"reference-count":87,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T00:00:00Z","timestamp":1646006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1116161"],"award-info":[{"award-number":["1116161"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1132902"],"award-info":[{"award-number":["1132902"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Following the availability of highly effective direct-acting antivirals (DAAs) to treat hepatitis C infection, the uptake of treatment by people living with hepatitis C rose dramatically in high- and middle-income countries but has since declined. To achieve the World Health Organization\u2019s (WHO) 2030 target to eliminate hepatitis C as a public health threat among people who inject drugs, an increase in testing and treatment is required, together with improved coverage of harm reduction interventions. The population that remains to be treated in high- and middle-income countries with high hepatitis C prevalence are among the most socially disadvantaged, including people who inject drugs and are involved in the criminal justice system, a group with disproportionate hepatitis C prevalence, compared with people in the wider community. Imprisonment provides an unrivalled opportunity for screening and treating large numbers of people for hepatitis C, who may not access mainstream health services in the community. Despite some implementation challenges, evidence of the efficacy, acceptability, and cost-effectiveness of in-prison hepatitis treatment programs is increasing worldwide, and evaluations of these programs have demonstrated the capacity for treating people in high numbers. In this Perspective we argue that the scale-up of hepatitis C prevention, testing, and treatment programs in prisons, along with the investigation of new and adapted approaches, is critical to achieving WHO elimination goals in many regions; the Australian experience is highlighted as a case example. We conclude by discussing opportunities to improve access to prevention, testing, and treatment for people in prison and other justice-involved populations, including harnessing the changed practices brought about by the COVID-19 pandemic.<\/jats:p>","DOI":"10.3390\/v14030497","type":"journal-article","created":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T20:11:57Z","timestamp":1646079117000},"page":"497","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["The Importance of Prisons in Achieving Hepatitis C Elimination: Insights from the Australian Experience"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2067-4278","authenticated-orcid":false,"given":"Rebecca J.","family":"Winter","sequence":"first","affiliation":[{"name":"Behaviours and Health Risks\/Disease Elimination Programs, Burnet Institute, Melbourne 3004, Australia"},{"name":"Department of Gastroenterology, St Vincent\u2019s Hospital Melbourne, Melbourne 3065, Australia"},{"name":"School of Public Health and Preventive Medicine, Monash University, Melbourne 3004, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacinta A.","family":"Holmes","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, St Vincent\u2019s Hospital Melbourne, Melbourne 3065, Australia"},{"name":"Department of Medicine, University of Melbourne, Melbourne 3010, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J.","family":"Papaluca","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, St Vincent\u2019s Hospital Melbourne, Melbourne 3065, Australia"},{"name":"Department of Medicine, University of Melbourne, Melbourne 3010, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander J.","family":"Thompson","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, St Vincent\u2019s Hospital Melbourne, Melbourne 3065, Australia"},{"name":"Department of Medicine, University of Melbourne, Melbourne 3010, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,2,28]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2022, February 24). Hepatitis C Factsheet, Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-c."},{"key":"ref_2","unstructured":"World Health Organization (2022, February 24). Interim Guidance for Country Validation of Viral Hepatitis Elimination, Available online: https:\/\/reliefweb.int\/sites\/reliefweb.int\/files\/resources\/Interim%20guidance%20for%20country%20validation%20of%20viral%20hepatitis%20elimination%20%28June%202021%29.pdf."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0140-6736(19)32320-7","article-title":"Hepatitis C","volume":"394","author":"Spearman","year":"2019","journal-title":"Lancet"},{"key":"ref_4","unstructured":"World Health Organization (2022, February 24). Global Health Sector Strategy on Viral Hepatitis 2016\u20132021. Towards Ending Viral Hepatitis, Available online: https:\/\/apps.who.int\/iris\/handle\/10665\/246177."},{"key":"ref_5","unstructured":"Burnet Institute and Kirby Institute (2021). Australia\u2019s Progress towards Hepatitis C Elimination: Annual Report 2021, Burnet Institute. Available online: https:\/\/burnet.edu.au\/system\/asset\/file\/5001\/BurnetKirby-hepC-2021-report.pdf."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/liv.14324","article-title":"Global timing of hepatitis C virus elimination in high-income countries","volume":"40","author":"Razavi","year":"2020","journal-title":"Liver Int."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Kwon, J.A., Dore, G.J., Hajarizadeh, B., Alavi, M., Valerio, H., Grebely, J., Guy, R., and Gray, R.T. (2021). Australia could miss the WHO hepatitis C virus elimination targets due to declining treatment uptake and ongoing burden of advanced liver disease complications. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0257369"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S2468-1253(20)30305-8","article-title":"Effect of the COVID-19 pandemic on viral hepatitis services in sub-Saharan Africa","volume":"5","author":"Lemoine","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S2468-1253(20)30238-7","article-title":"The impact of COVID-19 on hepatitis elimination","volume":"5","author":"Wingrove","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jhepr.2019.04.002","article-title":"Global progress on the elimination of viral hepatitis as a major public health threat: An analysis of WHO Member State responses 2017","volume":"1","author":"Smith","year":"2019","journal-title":"JHEP Rep."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1093\/cid\/cit296","article-title":"Combination Interventions to Prevent HCV Transmission Among People Who Inject Drugs: Modeling the Impact of Antiviral Treatment, Needle and Syringe Programs, and Opiate Substitution Therapy","volume":"57","author":"Martin","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.drugpo.2017.07.006","article-title":"Reaching hepatitis C virus elimination targets requires health system interventions to enhance the care cascade","volume":"47","author":"Scott","year":"2017","journal-title":"Int. J. Drug Policy"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"365","DOI":"10.5694\/mja2.50544","article-title":"Australia needs to increase testing to achieve hepatitis C elimination","volume":"212","author":"Scott","year":"2020","journal-title":"Med. J. Aust."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1093\/cid\/ciaa571","article-title":"Progress Towards Elimination of Hepatitis C Infection Among People Who Inject Drugs in Australia: The ETHOS Engage Study","volume":"73","author":"Valerio","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/dar.12883","article-title":"Uptake of direct acting antiviral therapies for the treatment of hepatitis C virus among people who inject drugs in a universal health-care system","volume":"38","author":"Butler","year":"2019","journal-title":"Drug Alcohol Rev."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1111\/liv.14043","article-title":"Disparities in uptake of direct-acting antiviral therapy for hepatitis C among people who inject drugs in a Canadian setting","volume":"39","author":"Ti","year":"2019","journal-title":"Liver Int."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"E431","DOI":"10.1016\/S2214-109X(20)30505-2","article-title":"Decentralisation, integration, and task-shifting in hepatitis C virus infection testing and treatment: A global systematic review and meta-analysis","volume":"9","author":"Oru","year":"2021","journal-title":"Lancet Glob. Health"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1093\/cid\/cit271","article-title":"Models of care for the management of hepatitis C virus among people who inject drugs: One size does not fit all","volume":"57","author":"Bruggmann","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e1192","DOI":"10.1016\/S2214-109X(17)30375-3","article-title":"Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: A multistage systematic review","volume":"5","author":"Degenhardt","year":"2017","journal-title":"Lancet Glob. Health"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1111\/add.13877","article-title":"Substance use disorders in prisoners: An updated systematic review and meta-regression analysis in recently incarcerated men and women","volume":"112","author":"Fazel","year":"2017","journal-title":"Addiction"},{"key":"ref_21","unstructured":"Walmsley, R. (2018). World Prison Population List, Institute for Criminal Policy Research, University of London. [12th ed.]. Available online: https:\/\/www.prisonstudies.org\/sites\/default\/files\/resources\/downloads\/wppl_12.pdf."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0140-6736(16)30466-4","article-title":"Global burden of HIV, viral hepatitis and tuberculosis among prisoners and detainees","volume":"388","author":"Dolan","year":"2016","journal-title":"Lancet"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/epirev\/mxy003","article-title":"HIV and Viral Hepatitis Among Imprisoned Key Populations","volume":"40","author":"Wirtz","year":"2018","journal-title":"Epidemiol. Rev."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/hep.26387","article-title":"Incidence and prevalence of hepatitis C in prisons and other closed settings: Results of a systematic review and meta-analysis","volume":"58","author":"Larney","year":"2013","journal-title":"Hepatology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1001\/jama.2012.374","article-title":"Screening for HCV infection in jails","volume":"307","author":"Spaulding","year":"2012","journal-title":"JAMA"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.drugpo.2017.12.013","article-title":"Longitudinal injecting risk behaviours among people with a history of injecting drug use in an Australian prison setting: The HITS-p study","volume":"54","author":"Cunningham","year":"2018","journal-title":"Int. J. Drug Policy"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1108\/IJPH-09-2014-0032","article-title":"Injecting drug use in prison: Prevalence and implications for needle exchange policy","volume":"11","author":"Wright","year":"2015","journal-title":"Int. J. Prison. Health"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.3748\/wjg.v17.i25.3027","article-title":"Prevalence, genotypes and factors associated with HCV infection among prisoners in Northeastern Brazil","volume":"17","author":"Santos","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s11524-019-00353-5","article-title":"The Prison and Transition Health (PATH) cohort study: Study protocol and baseline characteristics of a cohort of men with a history of injecting drug use leaving prison in Australia","volume":"96","author":"Kirwan","year":"2019","journal-title":"J. Urban Health"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.drugalcdep.2016.08.640","article-title":"Resumption of injecting drug use following release from prison in Australia","volume":"168","author":"Winter","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.drugalcdep.2014.11.021","article-title":"High-risk behaviors after release from incarceration among people who inject drugs in St. Petersburg, Russia","volume":"147","author":"Cepeda","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/S1473-3099(18)30469-9","article-title":"Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: A systematic review and meta-analysis","volume":"18","author":"Stone","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"ref_33","unstructured":"Alper, M., Durose, M.R., and Markman, J. (2022, February 24). 2018 Update on Prisoner Recidivism: A 9-Year Follow-Up Period (2005\u20132014), Available online: https:\/\/bjs.ojp.gov\/content\/pub\/pdf\/18upr9yfup0514.pdf."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"108970","DOI":"10.1016\/j.drugalcdep.2021.108970","article-title":"The Prison and Transition Health (PATH) cohort study: Prevalence of health, social, and crime characteristics after release from prison for men reporting a history of injecting drug use in Victoria, Australia","volume":"227","author":"Stewart","year":"2021","journal-title":"Drug Alcohol Depend."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/dar.12881","article-title":"Injecting drug use is an independent risk factor for reincarceration after release from prison: A prospective cohort study","volume":"38","author":"Winter","year":"2019","journal-title":"Drug Alcohol Rev."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1056\/NEJMp1311941","article-title":"Responding to hepatitis C through the criminal justice system","volume":"370","author":"Rich","year":"2014","journal-title":"N. Eng. J. Med."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver (2020). EASL recommendations on treatment of hepatitis C: Final update of the series. J. Hepatol., 73, 1170\u20131218.","DOI":"10.1016\/j.jhep.2020.08.018"},{"key":"ref_38","unstructured":"American Association for the Study of Liver Diseases, and Infectious Diseases Society of America (2019). HCV Testing and Treatment in Correctional Settings, AASLD. Available online: https:\/\/www.hcvguidelines.org\/unique-populations\/correctional."},{"key":"ref_39","unstructured":"Hepatitis C Virus Infection Consensus Statement Working Group (2020). Australian Recommendations for the Management of Hepatitis C Virus Infection: A Consensus Statement (June 2020), Gastroenterological Society of Australia. Available online: https:\/\/www.hepcguidelines.org.au\/."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S2468-1253(20)30365-4","article-title":"Hepatitis C elimination among people incarcerated in prisons: Challenges and recommendations for action within a health systems framework","volume":"6","author":"Akiyama","year":"2021","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"762","DOI":"10.7326\/0003-4819-144-10-200605160-00010","article-title":"A framework for management of HCV in prisons","volume":"144","author":"Spaulding","year":"2006","journal-title":"Ann. Int. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1155\/2004\/695483","article-title":"HIV and hepatitis C virus testing and seropositivity rates in Canadian federal penitentiaries: A critical opportunity for care and prevention","volume":"15","author":"De","year":"2004","journal-title":"Can. J. Infect. Dis. Med. Microbiol."},{"key":"ref_43","unstructured":"European Centre for Disease Prevention and Control (2022, February 24). Surveillance and Prevention of Hepatitis B and C in Europe, Available online: https:\/\/www.vhpb.org\/files\/2010%20ECDC%20report%20Surveillance%20and%20prevention%20of%20hepatitis%20B%20and%20C%20in%20Europe.pdf."},{"key":"ref_44","unstructured":"Australian Bureau of Statistics (2022, February 24). Prisoners in Australia. Cat No. 4517.0, Available online: https:\/\/www.abs.gov.au\/statistics\/people\/crime-and-justice\/prisoners-australia\/2021."},{"key":"ref_45","unstructured":"Australian Institute of Health and Welfare (2022, February 24). The Health of Australia\u2019s Prisoners 2018, Available online: https:\/\/www.aihw.gov.au\/reports\/prisoners\/health-australia-prisoners-2018\/."},{"key":"ref_46","unstructured":"Butler, T., and Simpson, M. (2017). National Prison Entrants\u2019 Blood-borne Virus Survey Report 2004, 2007, 2010, 2013, and 2016, Kirby Institute, UNSW. Available online: https:\/\/kirby.unsw.edu.au\/sites\/default\/files\/kirby\/report\/JHP_National-Prison-Entrants-Report-2004-2007-2010-2013-2016.pdf."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1111\/add.12643","article-title":"A prospective study of hepatitis C incidence in Australian prisoners","volume":"109","author":"Luciani","year":"2014","journal-title":"Addiction"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/jvh.12701","article-title":"Ongoing incident hepatitis C virus infection among people with a history of injecting drug use in an Australian prison setting, 2005\u20132014: The HITS-p study","volume":"24","author":"Cunningham","year":"2017","journal-title":"J. Viral Hepat."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.jhep.2019.01.012","article-title":"Outcomes of treatment for hepatitis C in prisoners using a nurse-led, statewide model of care","volume":"70","author":"Papaluca","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S1473-3099(19)30536-5","article-title":"Effective prison-based treatment and linkage to care after release","volume":"19","author":"Papaluca","year":"2019","journal-title":"Lancet Infect. Dis"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S2468-1253(21)00077-7","article-title":"Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): A prospective cohort study","volume":"6","author":"Hajarizadeh","year":"2021","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"391","DOI":"10.5694\/mja2.50140","article-title":"Scale-up of hepatitis C treatment in prisons is key to national elimination","volume":"210","author":"Papaluca","year":"2019","journal-title":"Med. J. Aust."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/cid\/cis1202","article-title":"Safety and effectiveness of a nurse-led outreach program for assessment and treatment of chronic hepatitis C in the custodial setting","volume":"56","author":"Lloyd","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1111\/jvh.12987","article-title":"Understanding facilitators and barriers of direct-acting antiviral therapy for hepatitis C virus infection in prison","volume":"25","author":"Lafferty","year":"2018","journal-title":"J. Viral Hepat."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/1753-6405.13007","article-title":"Australian first in Aboriginal and Torres Strait Islander prisoner health care in the Australian Capital Territory","volume":"44","author":"Shukralla","year":"2020","journal-title":"Aust. N. Z. J. Public Health"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.29913","article-title":"Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases","volume":"68","author":"Marrero","year":"2018","journal-title":"Hepatology"},{"key":"ref_57","first-page":"83","article-title":"The C-LINK Trial: A prospective randomised controlled trial showing that case management after release from prison increases linkage to hepatitis C care","volume":"35","author":"Papaluca","year":"2020","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Kwon, J.A., Chambers, G.M., Luciani, F., Zhang, L., Kinathil, S., Kim, D., Thein, H.-H., Botha, W., Thompson, S., and Lloyd, A. (2021). Hepatitis C treatment strategies in prisons: A cost-effectiveness analysis. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0245896"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"103203","DOI":"10.1016\/j.drugpo.2021.103203","article-title":"A costing analysis of a state-wide, nurse-led hepatitis C treatment model in prison","volume":"94","author":"Palmer","year":"2021","journal-title":"Int. J. Drug Policy"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"103379","DOI":"10.1016\/j.drugpo.2021.103379","article-title":"Hepatitis C treatment as prevention in the prison setting: Assessments of acceptability of treatment scale up efforts by prison correctional and health personnel","volume":"98","author":"Lafferty","year":"2021","journal-title":"Int. J. Drug Policy"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/cld.1023","article-title":"Hepatitis C Virus Prevalence, Screening, and Treatment Among People Who Are Incarcerated in Canada: Leaving No One Behind in the Direct-Acting Antiviral Era","volume":"17","author":"Bartlett","year":"2021","journal-title":"Clin. Liver Dis."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/add.14830","article-title":"Combined treatment and prevention strategies for hepatitis C virus elimination in the prisons in New South Wales: A modelling study","volume":"115","author":"Gray","year":"2020","journal-title":"Addiction"},{"key":"ref_63","unstructured":"Harm Reduction International (2020). The Global State of Harm Reduction 2020, Harm Reduction International. [7th ed.]. Available online: https:\/\/www.hri.global\/global-state-of-harm-reduction-2020."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/dar.13062","article-title":"Methamphetamine use, health and criminal justice system outcomes: A systematic review","volume":"39","author":"Cumming","year":"2020","journal-title":"Drug Alcohol Rev."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s40263-020-00711-x","article-title":"Pharmacological Treatment of Methamphetamine\/Amphetamine Dependence: A Systematic Review","volume":"34","author":"Siefried","year":"2020","journal-title":"CNS Drugs"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s11524-015-9945-4","article-title":"Comparison of risk-based hepatitis C screening and the true seroprevalence in an urban prison system","volume":"92","author":"Kuncio","year":"2015","journal-title":"J. Urban Health"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.2105\/AJPH.2004.056291","article-title":"A Missed Opportunity: Hepatitis C Screening of Prisoners","volume":"95","author":"Macalino","year":"2005","journal-title":"Am. J. Public Health"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1108\/HE-08-2020-0076","article-title":"Understanding and supporting the health literacy of young men in prison: A mixed-methods study","volume":"121","author":"Mehay","year":"2021","journal-title":"Health Educ."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s11524-018-0276-0","article-title":"Health Literacy Among a Formerly Incarcerated Population Using Data from the Transitions Clinic Network","volume":"95","author":"Hadden","year":"2018","journal-title":"J. Urban Health"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Kivimets, K., Uusk\u00fcla, A., Lazarus, J.V., and Ott, K. (2018). Hepatitis C seropositivity among newly incarcerated prisoners in Estonia: Data analysis of electronic health records from 2014 to 2015. BMC Infect. Dis., 18.","DOI":"10.1186\/s12879-018-3242-2"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1177\/0033354917732755","article-title":"Opt-out HIV and Hepatitis C Testing at the Dallas County Jail: Uptake, Prevalence, and Demographic Characteristics of Testers","volume":"132","author":"Porsa","year":"2017","journal-title":"Pub. Health Rep."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/eurpub\/ckv133","article-title":"Routine testing for blood-borne viruses in prisons: A systematic review","volume":"25","author":"Rumble","year":"2015","journal-title":"Eur. J. Public Health"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Greifinger, R.B. (2022). HIV and Hepatitis C in Corrections: A Public Health Opportunity. Public Health Behind Bars: From Prisons to Communities, Springer.","DOI":"10.1007\/978-1-0716-1807-3"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"102608","DOI":"10.1016\/j.drugpo.2019.102608","article-title":"Time matters: Point of care screening and streamlined linkage to care dramatically improves hepatitis C treatment uptake in prisoners in England","volume":"75","author":"Mohamed","year":"2020","journal-title":"Int. J. Drug Policy"},{"key":"ref_75","unstructured":"Sheehan, Y., Cunningham, E.B., Cochrane, A., Byrne, M., Brown, T., McGrath, C., Lafferty, L., Tedla, N., Lloyd, A.R., and Grebley, J. (2021, January 13\u201315). A \u2018one-stop-shop\u2019 intervention integrating point-of-care HCV RNA testing to enhance hepatitis C testing and treatment uptake among new receptions to prison: The PIVOT Study. Proceedings of the International Conference on Health and Hepatitis Care in Substance Users (INSHU), Sydney, Australia. virtual."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Akiyama, M.J., Columbus, D., MacDonald, R., Jordan, A.O., Schwartz, J., Litwin, A.H., Eckhardt, B., and Carmody, E. (2019). Linkage to hepatitis C care after incarceration in jail: A prospective, single arm clinical trial. BMC Infect. Dis., 19.","DOI":"10.1186\/s12879-019-4344-1"},{"key":"ref_77","unstructured":"European Centre for Disease Prevention and Control, and European Monitoring Centre for Drugs and Drug Addiction (2022, February 24). Public Health Guidance on Prevention and Control of Blood-Borne Viruses in Prison Settings, Available online: https:\/\/www.emcdda.europa.eu\/publications\/joint-publications\/ecdc\/guidance-blood-borne-viruses-in-prison_en."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Visher, C., Lavigne, N., and Travis, J. (2004). Returning Home: Understanding the Challenges of Prisoner Re-Entry, Urban Institute, Justice Policy Centre. Available online: https:\/\/www.urban.org\/sites\/default\/files\/publication\/42841\/410974-Returning-Home-Understanding-the-Challenges-of-Prisoner-Reentry.PDF.","DOI":"10.1037\/e720382011-001"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12954-020-00431-x","article-title":"Continuum of hepatitis C care cascade in prison and following release in the direct-acting antivirals era","volume":"17","author":"Hariri","year":"2020","journal-title":"Harm Reduct. J."},{"key":"ref_80","unstructured":"Australian Bureau of Statistics (2022, February 24). Corrective Services, Australia, June Quarter 2021, Available online: https:\/\/www.abs.gov.au\/statistics\/people\/crime-and-justice\/corrective-services-australia\/jun-quarter-2021."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Cabezas, J., Llerena, S., Mateo, M., \u00c1lvarez, R., Cobo, C., Gonz\u00e1lez, V., Martr\u00f3, E., Cuadrado, A., and Crespo, J. (2021). Hepatitis C Micro-Elimination beyond Prison Walls: Navigator-Assisted Test-and-Treat Strategy for Subjects Serving Non-Custodial Sentences. Diagnostics, 11.","DOI":"10.3390\/diagnostics11050877"},{"key":"ref_82","unstructured":"World Health Organization (2021, December 26). WHO Coronavirus (COVID-19) Dashboard. Available online: https:\/\/covid19.who.int\/."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/cld.1088","article-title":"Impact of COVID-19 Response on Hepatitis Prevention Care and Treatment: Results from Global Survey of Providers and Program Managers","volume":"17","author":"Laury","year":"2021","journal-title":"Clin. Liver Dis."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jhep.2020.07.042","article-title":"Impact of COVID-19 on global HCV elimination efforts","volume":"74","author":"Blach","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1056\/NEJMp2005687","article-title":"Flattening the Curve for Incarcerated Populations\u2014COVID in Jails and Prisons","volume":"382","author":"Akiyama","year":"2020","journal-title":"N. Eng. J. Med."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40352-021-00150-w","article-title":"A rapid review of early guidance to prevent and control COVID-19 in custodial settings","volume":"9","author":"Pearce","year":"2021","journal-title":"Health Justice"},{"key":"ref_87","unstructured":"UN General Assembly (2015). UN Standard Minimum Rules for the Treatment of Prisoners (the Nelson Mandela Rules), United Nations. Available online: https:\/\/www.unodc.org\/documents\/justice-and-prison-reform\/Nelson_Mandela_Rules-E-ebook.pdf."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/14\/3\/497\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:29:18Z","timestamp":1760135358000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/14\/3\/497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,28]]},"references-count":87,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,3]]}},"alternative-id":["v14030497"],"URL":"https:\/\/doi.org\/10.3390\/v14030497","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,28]]}}}